JR
BNR

Josh Resnick’s Burning Rock Biotech BNR Stock Holding History

Josh Resnick’s Portfolio BNR Stock Details BNR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-2,000
Closed -$540K – 47
2020
Q2 		$540K Buy
+2,000
New +$548K 0.02% 48

Other funds holding BNR

O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
MICM
Matthews International Capital Management San Francisco, California $292M AUM 75.01% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $181B AUM 41.77% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $36.8B AUM 42.13% 1-Year Est. Return
HSBC Holdings
HSBC Holdings London, United Kingdom $239B AUM 42.32% 1-Year Est. Return

Josh Resnick's BNR Position: Q3 2020 in Review

Josh Resnick sold out of Burning Rock Biotech (BNR) in Q3 2020, closing a stake of 2,000 shares — an estimated $540K sold.

Josh Resnick first reported a position in BNR in Q2 2020 and held it in 1 quarter. The position peaked at $540K in Q2 2020. 38 funds tracked by Wall St. Rank hold BNR as of Q3 2020.

  • Josh Resnick reported no remaining Burning Rock Biotech position as of Q3 2020 after selling out during the quarter.
  • Josh Resnick sold 2,000 Burning Rock Biotech shares in Q3 2020, an estimated $540K.
  • Josh Resnick first reported a position in Burning Rock Biotech in Q2 2020 and held it in 1 quarter.
  • Josh Resnick's Burning Rock Biotech position peaked at $540K in Q2 2020.
  • 38 funds tracked by Wall St. Rank held Burning Rock Biotech as of Q3 2020.

Based on Jericho Capital Asset Management's 13F filing for Q3 2020, filed 16 Nov 2020.